Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
13:26 | Boehringer's Jascayd gains NMPA approval for idiopathic pulmonary fibrosis | ||
Mi | Portal Therapeutics receives FDA orphan, fast track designations for PORT-77 | ||
Di | Citius Oncology finalises McKesson deal for Lymphir distribution | ||
Fr | Tempus partners with Whitehawk on oncology research | ||
16.10. | FDA accepts Chiesi triple combination inhaler application for asthma | ||
15.10. | iQure, University of Padova collaborate to investigate iQ-007 mechanism | ||
14.10. | US FDA grants BeOne's sonrotoclax breakthrough designation for MCL | ||
13.10. | Adcendo receives FDA fast track status for ADCE-D01 to treat STS | ||
10.10. | Bio-Thera, Intas extend partnership for golimumab biosimilar | ||
09.10. | Nilo Therapeutics raises $101m to develop neural circuit therapies | ||
08.10. | AeroRx secures $21m for nebulised COPD treatment development | ||
07.10. | FDA accepts priority review for Orca Bio's hematological malignancy therapy | ||
06.10. | FDA fast-tracks Alto Neuroscience's ALTO-101 for CIAS treatment | ||
01.10. | FDA approves Novartis' Rhapsido for CSU treatment | ||
30.09. | BioLineRx partners with Hemispherian to advance brain cancer therapy | ||
29.09. | AbbVie files NDA with FDA for tavapadon to treat Parkinson's disease | ||
26.09. | Lilly secures EC approval for Kisunla to treat Alzheimer's disease | ||
25.09. | Sandoz launches generic iron sucrose injection in US market | ||
24.09. | Leqembi approved in Australia to treat early Alzheimer's | ||
23.09. | Avenzo Therapeutics secures $60m in series B funding for oncology therapies | ||
22.09. | J&J's Tremfya gets FDA approval for SC induction in active UC | ||
19.09. | Biogen to acquire Alcyone Therapeutics for $85m | ||
18.09. | Deciphera's Romvimza secures EC nod for TGCT treatment | ||
17.09. | Dualitas secures $65m for bispecific antibody pipeline | ||
16.09. | Argo Biopharma secures NMPA clearance for Phase II PNH trial |